#ExistRefRange>Effective August 20, 2012
0.0 - 7.4 ng/mL
#ExistInterpData>The µTASWako method is used. Results obtained with different assay methods or kits cannot be used interchangeably. The des-gamma-carboxy prothrombin (DCP) assay is intended as a risk assessment for the development of hepatocellular carcinoma in patients with chronic liver diseases. Elevated DCP values have been shown to be associated with an increased risk for developing hepatocellular carcinoma. Patients with elevated serum DCP should be more intensely evaluated for evidence of hepatocellular carcinoma.
||DCP (Des-gamma-carboxy Prothrombin), PIVKA-II (Protein Induced by Vitamin K Absence or Antagonist II) (Des-gamma-carboxy Prothrombin)